Honglv Jiang
Jiangsu Key Laboratory Of Drug Discovery And Translational Research For Brain Diseases And College Of Pharmaceutical Sciences, Jiangsu Key Laboratory Of Preventive And Translational Medicine For Major Chronic Non Communicable Diseases, Suzhou Key Laboratory Of Drug Research For Prevention And Treatment Of Hyperlipidemic Diseases
Suzhou, 215123, China
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
SQSTM1/p62 UFMylation Enhances Autophagic Clearance of Pathogenic Mutant Huntingtin.
Journal: International journal of biological sciences
Published: October 22, 2025
Proteomic and network pharmacology analyses reveal S100A8 as the anti-inflammatory target of Yunpi Jiedu Tongluo Qushi Granule in the treatment of rheumatoid arthritis.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 21, 2024
Ephrin B3 exacerbates colitis and colitis-associated colorectal cancer.
Journal: Biochemical pharmacology
Published: August 07, 2023
The fine-tuned crosstalk between lysine acetylation and the circadian rhythm.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: June 18, 2023
Proximity Proteomics and Biochemical Analysis Reveal a Noncanonical Function for UFM1-Specific Protease 1 in the p62 Body Formation.
Journal: Journal of proteome research
Published: June 07, 2023
Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo.
Journal: Chinese herbal medicines
Published: May 22, 2023
The aryl sulfonamide indisulam inhibits gastric cancer cell migration by promoting the ubiquitination and degradation of the transcription factor ZEB1.
Journal: The Journal of biological chemistry
Published: October 03, 2022
Proteomics and Biochemical Analyses of Secreted Proteins Revealed a Novel Mechanism by Which ADAM12S Regulates the Migration of Gastric Cancer Cells.
Journal: Journal of proteome research
Published: August 04, 2022
Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis.
Journal: iScience
Published: July 12, 2022
RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 29, 2022
Last Updated: 09/26/2026